A Comparison of PF708 and Forteo in Osteoporosis Patients

NCT03002428 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Teriparatide (PF708)
DRUG: Teriparatide (Forteo)

Sponsor

Pfenex, Inc